Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

PTBPs: An immunomodulatory-related prognostic biomarker in pan-cancer

23 Aug 2022

Abstract excerpt

Background: The polypyrimidine tract-binding protein (PTBP) nuclear ribonucleoprotein family of proteins, including PTBP1, PTBP2 and PTBP3, regulate the process of cell proliferation, differentiation, apoptosis and carcinogenesis. PTBPs exhibit oncogenic effects in certain tumors. However, the role of PTBPs in pan-cancer remains unclear. Our study examined the clinical significance and mechanism of PTBPs in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to Ferroptosis and cancer prognosis
Share to Lung Cancer Treatments and Mutations

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36203873
DOI: 10.3389/fmolb.2022.968458

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

PTBPs: An immunomodulatory-related prognostic biomarker in pan-cancerPMID 36203873Read ↗

IGF2BP3 expression in pan-cancer: A bioinformatics-based study of its prognostic relevance and immunological roleSemantic proximity Read ↗

Comprehensive analysis of the prognostic value of PEBP4 in pan-cancersSemantic proximity Read ↗

Pan-Cancer Analysis of PIMREG as a Biomarker for the Prognostic and Immunological RoleSemantic proximity Read ↗

Comprehensive pan-cancer analysis reveals NUSAP1 is a novel predictive biomarker for prognosis and immunotherapy responseSemantic proximity Read ↗

Potential Value of PRKDC as a Therapeutic Target and Prognostic Biomarker in Pan-CancerSemantic proximity Read ↗

An integrated pan-cancer analysis of TFAP4 aberrations and the potential clinical implications for cancer immunity.Semantic proximity Read ↗

AP3S1 is a Novel Prognostic Biomarker and Correlated With an Immunosuppressive Tumor Microenvironment in Pan-CancerSemantic proximity Read ↗

Prognostic significance and immunologic features of the paired-box (PAXs) family: a pan-cancer multi- omics analysisSemantic proximity Read ↗

Multi-omics analysis of N6-methyladenosine reader IGF2BP3 as a promising biomarker in pan-cancerSemantic proximity Read ↗

Cyclin B1: A potential prognostic and immunological biomarker in pan-cancerSemantic proximity Read ↗

A TP53-Associated Immune Prognostic Signature for the Prediction of Overall Survival and Therapeutic Responses in Muscle-Invasive Bladder Cancer.Semantic proximity Read ↗

Identifying survival of pan-cancer patients under immunotherapy using genomic mutation signature with large sample cohorts.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.